Hennion & Walsh Asset Management, Inc. Celcuity Inc. Transaction History
Hennion & Walsh Asset Management, Inc.
- $2.35 Billion
- Q2 2025
A detailed history of Hennion & Walsh Asset Management, Inc. transactions in Celcuity Inc. stock. As of the latest transaction made, Hennion & Walsh Asset Management, Inc. holds 174,493 shares of CELC stock, worth $7.71 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
174,493
Previous 168,740
3.41%
Holding current value
$7.71 Million
Previous $1.79 Million
30.48%
% of portfolio
0.1%
Previous 0.08%
Shares
5 transactions
Others Institutions Holding CELC
# of Institutions
100Shares Held
30.6MCall Options Held
16.2KPut Options Held
51.9K-
Baker Bros. Advisors LP New York, NY4.26MShares$188 Million0.51% of portfolio
-
Bvf Inc San Francisco, CA3.47MShares$153 Million1.54% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.57MShares$114 Million2.15% of portfolio
-
Perceptive Advisors LLC New York, NY2.36MShares$104 Million1.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.67MShares$73.9 Million0.0% of portfolio
About Celcuity Inc.
- Ticker CELC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,941,300
- Market Cap $660M
- Description
- Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...